Tanaka Hirotomo, Sasayama Takashi, Nishihara Masamitsu, Arai Atsushi, Kawamura Atsufumi, Kanomata Naoki, Itoh Tomoo, Kohmura Eiji
Department of Neurosurgery, Kobe University Graduate School of Medicine, Kobe, Hyogo.
Neurol Med Chir (Tokyo). 2010;50(8):689-93. doi: 10.2176/nmc.50.689.
A 33-year-old woman presented with rare brain metastases from undifferentiated high-grade sarcoma manifesting as headache and vomiting. Magnetic resonance (MR) imaging demonstrated multiple tumors in the brain, subcutaneous soft tissue, and mediastinum. The patient underwent surgery, followed by chemotherapy and radiotherapy. The histological diagnosis was undifferentiated high-grade sarcoma. Radiotherapy was effective, but the brain tumors recurred 6 months later. The patient underwent high-dose methotrexate therapy, but showed no response. Promoter hypermethylation in the O(6)-methylguanine-deoxyribonucleic acid methyltransferase (MGMT) genes was detected and MGMT protein expression was negative in the recurrent tumor, so temozolomide (TMZ) salvage chemotherapy was given, and follow-up MR imaging showed tumor reduction. This case suggests that TMZ may be effective for brain metastasis of undifferentiated sarcoma without MGMT protein expression.
一名33岁女性因未分化高级别肉瘤罕见脑转移而出现头痛和呕吐症状。磁共振成像显示脑内、皮下软组织及纵隔有多处肿瘤。患者接受了手术,随后进行化疗和放疗。组织学诊断为未分化高级别肉瘤。放疗有效,但6个月后脑肿瘤复发。患者接受了大剂量甲氨蝶呤治疗,但无反应。检测到复发肿瘤中O(6)-甲基鸟嘌呤-脱氧核糖核酸甲基转移酶(MGMT)基因启动子高甲基化且MGMT蛋白表达阴性,因此给予替莫唑胺(TMZ)挽救性化疗,后续磁共振成像显示肿瘤缩小。该病例提示TMZ可能对无MGMT蛋白表达的未分化肉瘤脑转移有效。